Projects overview

Sort by

Toggle all information

QIandQD | The first IVDR-approved commercial software solutions for AI-powered RNA-based companion and precision cancer diagnostics of acute myeloid leukaemia and bladder cancer

01-05-2024

-

30-04-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.3 Innovative Europe
HORIZON.3.1 The European Innovation Council (EIC)
HORIZON.3.1.0 Cross-cutting call topics
HORIZON-EIC-2023-ACCELERATOR-01
HORIZON-EIC-2023-ACCELERATORCHALLENGES-01 EIC Accelerator Challenge: Novel biomarker-based assays to guide personalised cancer treatment

IOO - Improving IO | IOO: a novel assay to predict patient response to immune checkpoint inhibitors, optimising patient stratification to these therapies and tripling solid tumour patient outcomes in immuno-oncology.

01-08-2024

-

31-07-2026

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.3 Innovative Europe
HORIZON.3.1 The European Innovation Council (EIC)
HORIZON.3.1.0 Cross-cutting call topics
HORIZON-EIC-2023-ACCELERATOR-01
HORIZON-EIC-2023-ACCELERATORCHALLENGES-01 EIC Accelerator Challenge: Novel biomarker-based assays to guide personalised cancer treatment

Histotype Px | Precision biomarker based on digital pathology and artificial intelligence to guide fast and cost-effective personalized treatment decision support for colorectal cancer patients

01-06-2024

-

31-05-2026

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.3 Innovative Europe
HORIZON.3.1 The European Innovation Council (EIC)
HORIZON.3.1.0 Cross-cutting call topics
HORIZON-EIC-2023-ACCELERATOR-01
HORIZON-EIC-2023-ACCELERATORCHALLENGES-01 EIC Accelerator Challenge: Novel biomarker-based assays to guide personalised cancer treatment
Powered by Chris Decubber BV